The company also said it hoped to start trials in August of an easier-to-use inhaled version of the medicine, currently administered only intravenously
from Latest News https://ift.tt/2Z3xmm4
Monday, 22 June 2020
Gilead aims remdesivir supply for 2 million Covid-19 patients by year-end
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment